Obinutuzumab-induced coagulopathy in chronic lymphocytic leukaemia with trisomy 12.
Ernest and Helen Scott Haematological Research Institute, University of Leicester, Leicester, UK.
H S
HS
Walter
Ernest and Helen Scott Haematological Research Institute, University of Leicester, Leicester, UK.
S
S
Jayne
Department of Haematology, University Hospitals Leicester, Leicester, UK.
P
P
Mensah
Department of Haematology, University Hospitals Leicester, Leicester, UK.
F M
FM
Miall
Department of Haematology, Kettering Hospital NHS Trust, Kettering, UK.
M
M
Lyttelton
Ernest and Helen Scott Haematological Research Institute, University of Leicester, Leicester, UK.
M J S
MJ
Dyer
D000368:Aged; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects*; D002881:Chromosomes, Human, Pair 12; D004211:Disseminated Intravascular Coagulation / Q000139:chemically induced*; D005260:Female; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000150:complications / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology; D009154:Mutation; D051881:Receptor, Notch1 / Q000235:genetics; D014314:Trisomy / Q000235:genetics / Q000473:pathology
D061067:Antibodies, Monoclonal, Humanized; C497761:NOTCH1 protein, human; D051881:Receptor, Notch1; C543332:obinutuzumab